Welcome to our dedicated page for Optimus Healthcare Services SEC filings (Ticker: OHCS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Optimus Healthcare Services's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Optimus Healthcare Services's regulatory disclosures and financial reporting.
Optimus Healthcare Services, Inc. outlines its final wind down after a prior strategic review found no viable alternatives to fund operations or cure defaults under its senior secured convertible notes. The company previously repaid a secured loan from JP Morgan Chase Bank and kept a small team to manage regulatory obligations and transition patient care from oncology trials.
On July 14, 2026, Optimus agreed with its first‑priority secured lender, Arena Investors, LP as agent for noteholders, to settle $4.4 million in secured debt plus accrued interest. The company will deliver its remaining cash, after essential wind‑down expenses, to the lender. After a final payment expected on or about July 31, 2026, the notes will be deemed terminated, the company and its officers and directors will receive a release, operations will cease, bank accounts will be closed, and all directors and officers will resign effective August 5, 2026.